Search results
Results from the WOW.Com Content Network
Iodine-131 (131 I, I-131) is an important radioisotope of iodine discovered by Glenn Seaborg and John Livingood in 1938 at the University of California, Berkeley. [3] It has a radioactive decay half-life of about eight days. It is associated with nuclear energy, medical diagnostic and treatment procedures, and natural gas production.
Iodine-131 (131 I) is the most common RNT worldwide and uses the simple compound sodium iodide with a radioactive isotope of iodine. The patient (human or animal) may ingest an oral solid or liquid amount or receive an intravenous injection of a solution of the compound. The iodide ion is selectively taken up by the thyroid gland.
The beta particles emitted by the radioisotope destroys the associated thyroid tissue with little damage to surrounding tissues (more than 2.0 mm from the tissues absorbing the iodine). Due to similar destruction, 131 I is the iodine radioisotope used in other water-soluble iodine-labeled radiopharmaceuticals (such as MIBG) used therapeutically ...
This page lists radioactive nuclides by their half-life.
Iodine-125 is a radioactive isotope of iodine that decays by electron capture with a physical half-life of 60.14 days. The biological half-life in normal individuals for iodine (125 I) human albumin has been reported to be approximately 14 days. Its radioactivity is excreted almost exclusively via the kidneys.
Iodine is a chemical element with many uses in medicine, depending on the form. Elemental iodine and iodophors are topical antiseptics. [2] Iodine, in non-elemental form, functions as an essential nutrient in human biology (see iodine in biology). [3] Organic compounds containing iodine are also useful iodinated contrast agents in X-ray imaging ...
Rae’s global monthly listeners on Spotify have increased by more than 450 percent, hitting an all-time career-high with 8.2 million, Variety can confirm. She’s also gotten a 1,180 percent year ...
The Iodine Global Network was founded in 1986, with its inaugural meeting held in Kathmandu, Nepal. [1] In 2002, the Network for Sustained Elimination of Iodine Deficiency was launched at the Special Session for Children. In 2012, the two organizations combined to form IGN. [1]